Ribozymes as therapeutic tools for genetic disease

Human Molecular Genetics

Volumn 7, Issue 10, 1998, Pages 1649-1653

  Phylactou, Leonidas A ^a   Kilpatrick, Michael W ^b   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; RNA;

GENE EXPRESSION REGULATION; GENE THERAPY; PRIORITY JOURNAL; REVIEW; RNA CLEAVAGE; RNA SPLICING; VIRUS INFECTION;

ANIMALS; DOWN-REGULATION; GENE THERAPY; GENES, DOMINANT; GENETIC DISEASES, INBORN; HUMANS; INTRONS; MUTATION; NUCLEIC ACID CONFORMATION; RNA; RNA SPLICING; RNA, CATALYTIC;

RNA VIRUSES;

EID: 0031665678     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.10.1649     Document Type: Review

References (54)

1. Guerrier Takada, C. and Altman, S. (1984) Catalytic activity of an RNA molecule prepared by transcription in vitro. Science, 223, 285-286.
2. Cech, T.R., Zaug, A.J. and Grabowski, P.J. (1981) In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell, 27, 487-496.
3. Cech, T.R. (1987) The chemistry of self-splicing RNA and RNA enzymes. Science, 236, 1532-1539.
4. Symons, R.H. (1989) Self-cleavage of RNA in the replication of small pathogens of plants and animals. Trends Biochem. Sci., 14, 445-450.
5. Joyce, G.F. (1996) Building the RNA world. Ribozymes. Curr. Biol., 6, 965-967.
6. Haseloff, J. and Gerlach, W.L. (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature, 334, 585-591.
7. Sarver, N., Cantin, E.M., Chang, P.S., Zaia, J.A., Ladne, P.A., Stephens, D.A. and Rossi, J.J. (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science, 247, 1222-1225.
8. Steinecke, P., Herget, T. and Schreier, P.H. (1992) Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo. EMBO J., 11, 1525-1530.
9. Rossi, J.J. (1995) Controlled, targeted, intracellular expression of ribozymes: progress and problems. Trends Biotechnol., 13, 301-306.
10. Thompson, J.D., Macejak, D., Couture, L. and Stinchcomb, D.T. (1995) Ribozymes in gene therapy. Nature Med., 1, 277-278.
11. James, W. and al Shamkhani, A. (1995) RNA enzymes as tools for gene ablation. Curr. Opin. Biotechnol., 6, 44-49.
12. Gibson, S.A. and Shillitoe, E.J. (1997) Ribozymes. Their functions and strategies for their use. Mol. Biotechnol., 7, 125-137.
13. Shimayama, T., Nishikawa, S. and Taira, K. (1995) Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. Biochemistry, 34, 3649-3654.
14. Burke, J.M. (1996) Hairpin ribozyme: current status and future prospects. Biochem. Soc. Trans., 24, 608-615.
15. Kiehntopf, M., Esquivel, E.L., Brach, M.A. and Herrmann, F. (1995) Clinical applications of ribozymes. Lancet, 345, 1027-1031.
16. Couture, L.A. and Stinchcomb, D.T. (1996) Anti-gene therapy: the use of ribozymes to inhibit gene function. Trends Genet., 12, 510-515.
17. Morgan, R.A. and Anderson, W.F. (1993) Human gene therapy. Annu. Rev. Biochem., 62, 191-217.
18. Lieber, A. and Kay, M.A. (1996) Adenovirus-mediated expression of ribozymes in mice. J. Virol., 70, 3153-3158.
19. Rossi, J.J. (1994) Practical ribozymes. Making ribozymes work in cells. Curr. Biol., 4, 469-471.
20. Kilpatrick, M.W., Phylactou, L.A., Godfrey, M., Wu, C.H., Wu, G.Y. and Tsipouras, P. (1996) Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts. Hum. Mol. Genet., 5, 1939-1944.
21. Sakamoto, N., Wu, C.H. and Wu, G.Y. (1996) Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. J. Clin. Invest., 98, 2720-2728.
22. Sun, L.Q., Wang, L., Gerlach, W.L. and Symonds, G. (1995) Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res., 23, 2909-2913.
23. Lisziewicz, J., Sun, D., Smythe, J., Lusso, P., Lori, F., Louie, A., Markham, P., Rossi, J., Reitz, M. and Gallo, R.C. (1993) Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl Acad. Sci. USA, 90, 8000-8004.
24. Crisell, P., Thompson, S. and James, W. (1993) Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res., 21, 5251-5255.
25. Yu, M., Ojwang, J., Yamada, O., Hampel, A., Rapapport, J., Looney, D. and Wong Staal, F. (1993) A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 90, 6340-6344.
26. Ohta, Y., Kijima, H., Kashani Sabet, M. and Scanlon, K.J. (1996) Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymes. J. Invest. Dermatol., 106, 275-280.
27. Grassi, G., Forlino, A. and Marini, J.C (1997) Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. Nucleic Acids Res., 25, 3451-3458.
28. Zoumadakis, M., Neubert, W.J. and Tabler, M. (1994) The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes. Nucleic Acids Res., 22, 5271-5278.
29. Werner, M. and Uhlenbeck, O.C. (1995) The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis. Nucleic Acids Res., 23, 2092-2096.
30. Ellis, J. and Rogers, J. (1993) Design and specificity of hammerhead ribozymes against calretinin mRNA. Nucleic Acids Res., 21, 5171-5178.
31. Pyeritz, R.E. and McKusick, V.A. (1979) The Marfan syndrome: diagnosis and management. N. Engl. J. Med., 300, 772-777.
32. Tsipouras, P., Del Mastro, R., Sarfarazi, M., Lee, B., Vitale, E., Child, A.H., Godfrey, M., Devereux, R.B., Hewett, D., Steinmann, B., Viljoen, D., Sykes, B.C., Kilpatrick, M. and Ramirez, F. (1992) Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N. Engl. J. Med., 326, 905-909.
33. Dietz, H.C., Cutting, G.R., Pyeritz, R.E., Maslen, C.L., Sakai, L.Y., Corson, G.M., Puffenberger, E.G., Hamosh, A., Nanthakumar, E.J., Curristin, S.M., Stetten, G., Meyers, D.A. and Francomano, C.A. (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 352, 337-339.
34. Hewett, D.R., Lynch, J.R., Smith, R. and Sykes, B.C. (1993) A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. Hum. Mol. Genet., 2, 475-477.
35. Godfrey, M., Vandemark, N., Wang, M., Velinov, M., Wargowski, D., Tsipouras, P., Han, J., Becker, J., Robertson, W., Droste, S. and Rao, V.H. (1993) Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome. Am. J. Hum. Genet., 53, 472-480.
36. Dietz, H.C., Valle, D., Francomano, C.A., Kendzior, R.J. Jr, Pyeritz, R.E. and Cutting, G.R. (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science, 259, 680-683.
37. Dietz, H.C. and Pyeritz, R.E. (1995) Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Mol. Genet., 4, 1799-1809.
38. Heidenreich, O., Benseler, F., Fahrenholz, A. and Eckstein, F. (1994) High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleosides and phosphorothioates. J. Biol. Chem., 269, 2131-2138.
39. Sproat, B.S. (1995) Chemistry and applications of oligonucleotide analogues. J. Biotechnol., 41, 221-238.
40. Usman, N., Beigelman. L. and McSwiggen, J.A. (1996) Hammerhead ribozyme engineering. Curr. Opin. Struct. Biol., 6, 527-533.
41. Cech, T.R. (1990) Self-splicing of group I introns. Annu. Rev. Biochem., 59, 543-568.
42. Sullenger, B.A. and Cech, T.R. (1994) Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing. Nature, 371, 619-622.
43. Jones, J.T., Lee, S.W. and Sullenger, B.A. (1996) Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nature Med., 2, 643-648.
44. Phylactou, L.A., Darrah, C. and Wood, M.J.A. (1998) Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nature Genet., 18, 378-381.
45. Harper, P.S. (1989) Myotonic Dystrophy. WB Saunders, Philadelphia, PA.
46. Shelbourne, P. and Johnson, K. (1992) Myotonic dystrophy: another case of too many repeats? Hum. Mutat., 1, 183-189.
47. Davies, K.E., Jackson, J., Williamson, R., Harper, P.S., Ball, S., Sarfarazi, M., Meredith, L. and Fey, G. (1983) Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe. J. Med. Genet., 20, 259-263.
48. Buxton, J., Shelbourne, P., Davies, J., Jones, C., Van Tongeren, T., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B., Williamson, R. and Johnson, K. (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature, 355, 547-548.
49. Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T., Sohn, R. and Zemelman, B. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of transcript encoding a protein kinase family member. Cell, 68, 799-808.
50. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barcelo, J., O'Hoy, K., Leblond, S., Earl-MacDonald, J., De Jong, P., Wieringa, B. and Korneluk, R.G. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science, 255, 1253-1255.
51. Tsilfidis, C., Mackenzie, A.E., Mettler, G., Barcelo, J. and Korneluk, R.G. (1992) Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet., 1, 192-195.
52. Hamshere, M.G. and Brook, J.D. (1996) Myotonic dystrophy, knockouts, warts and all. Trends Genet., 12, 332-334.
53. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. and Housman, D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA, 94, 7388-7393.
54. Young, B., Herschlag, D. and Cech, T.R. (1991) Mutations in a nonconserved sequence of the Tetrahymena ribozyme increase activity and specificity. Cell. 67, 1007-1019.